There are some incredible deals in biotech that have been overlooked by investors. Hemostemix (HMTXF: OTCMKTS) has award-winning technology in stem cell...
Vaccines have less efficacy with COVID-19 variants Key 3CL protease inhibitors shows promise for any COVID-19 variants, and potentially all coronav...
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) an...
On Oct. 30, Synacor, Inc. (NASDAQ:SYNC) announced its financial results for the third quarter of 2014. For the third quarter of 2014,...
Gold miner Kinross Gold Corporation (NYSE:KGC) posted adjusted earnings of $70.1 million or 6 cents per share in the third quarter of...
Aetna Inc. (NYSE:AET) released that that it has signed into a contract to purchase privately held bswift, which provides a technology platform...
GT Advanced Technologies Inc.’s latest agreement with Apple Inc. (NASDAQ:AAPL) is in jeopardy following a judge’s ruling to not keep circumstances surrounding...
International Flavors & Fragrances Inc. (IFF) will released its Q3 2014 results on Nov 4 before the market opens. The Zacks Consensus...
Bristol-Myers Squibb Company (NYSE:BMY) and Lonza reported that a multi-year extension of their obtainable biologics manufacturing contract. The contract extension will include...
Bristol-Myers Squibb Company (NYSE:BMY) and F-star Alpha Ltd. declared that the firm together with the F-star Alpha Ltd. shareholders, have signed into...